Every year, thousands of brain tumors are missed because of the limitations of human cognition, denying patients the best possible care.
With automated detection and tracking, our mission is to make cancer diagnosis and treatment faster and more precise.
Detection and measurement
AFX-BM suggests the location of potential brain metastases on contrasted T1 brain MRI images.
Largest bidirectional diameters are automatically derived from the generated segmentation.
Individual findings are listed along with their size for easy navigation.
Once approved, each finding is assigned a unique lesion label, persistent across studies.
Approved findings corresponding to the same lesion are automatically associated between studies.
This association enables longitudinal tracking of individual lesion, facilitating estimation of clinical endpoints like RECIST or RANO-BM.
Detailed PDF report, concisely summarizing longitudinal data, including tables of tracked findings and graphical displays of lesion size progression.